STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED Our Company Was .

RED HERRING PROSPECTUSDated: November 19, 2021Please read Section 32 of the Companies Act, 2013100% Book Built OfferSTAR HEALTH AND ALLIED INSURANCE COMPANY LIMITEDOur Company was incorporated as Star Health and Allied Insurance Company Limited, a public limited company, at Chennai under the Companies Act, 1956 on June 17, 2005 and was granted the certificate of incorporation by theRegistrar of Companies, Tamil Nadu at Chennai. Our Company was granted its certificate for commencement of business on December 9, 2005 by the RoC. For details see, “History and Certain Corporate Matters” on page 204.Registered and Corporate Office: No.1, New Tank Street,Valluvarkottam High Road, Nungambakkam, Chennai Tamil Nadu 600 034 India ; Tel: 91 44 2828 8800Website: www.starhealth.in; Contact Person: Jayashree Sethuraman, Company Secretary and Compliance Officer; E-mail: investors@starhealth.inCorporate Identity Number: U66010TN2005PLC056649IRDAI Registration Number: 129OUR PROMOTERS: SAFECROP INVESTMENTS INDIA LLP, WESTBRIDGE AIF I AND RAKESH JHUNJHUNWALAINITIAL PUBLIC OFFER OF UP TO [ ] EQUITY SHARES OF FACE VALUE OF 10 EACH (“EQUITY SHARES”) OF STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED (“COMPANY” OR “ISSUER”) FOR CASH AT A PRICE OF [ ]PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF [ ] PER EQUITY SHARE) AGGREGATING UP TO [ ] MILLION (THE “OFFER”) COMPRISING A FRESH ISSUE OF UP TO [ ] EQUITY SHARES AGGREGATING UP TO 20,000MILLION (THE “FRESH ISSUE”) AND AN OFFER FOR SALE OF UP TO 58,324,225 EQUITY SHARES, INCLUDING UP TO 30,683,553 EQUITY SHARES BY SAFECROP INVESTMENTS INDIA LLP (“PROMOTER SELLING SHAREHOLDER”), UPTO 137,816 EQUITY SHARES BY KONARK TRUST, UP TO 9,518 EQUITY SHARES BY MMPL TRUST (“PROMOTER GROUP SELLING SHAREHOLDERS”) UP TO 7,680,371 EQUITY SHARES BY APIS GROWTH 6 LIMITED, UP TO 4,110,652EQUITY SHARES BY MIO IV STAR, UP TO 7,438,564 EQUITY SHARES BY UNIVERSITY OF NOTRE DAME DU LAC, UP TO 4,110,652 EQUITY SHARES BY MIO STAR, UP TO 2,509,099 EQUITY SHARES BY ROC CAPITAL PTY LIMITED, UP TO1,000,000 EQUITY SHARES BY VENKATASAMY JAGANNATHAN, UP TO 500,000 EQUITY SHARES BY SAI SATISH AND UP TO 144,000 EQUITY SHARES BY BERJIS MINOO DESAI (COLLECTIVELY, THE “OTHER SELLING SHAREHOLDERS”AND COLLECTIVELY WITH THE PROMOTER SELLING SHAREHOLDER AND PROMOTER GROUP SELLING SHAREHOLDERS ARE REFERRED TO AS THE “SELLING SHAREHOLDERS”, AND SUCH EQUITY SHARES, THE “OFFEREDSHARES”) AGGREGATING UP TO [ ] MILLION (THE “OFFER FOR SALE”). THE OFFER SHALL CONSTITUTE [ ]% OF THE POST-OFFER PAID-UP EQUITY SHARE CAPITAL OF OUR COMPANY. THE OFFER INCLUDES A RESERVATIONOF UP TO [ ] EQUITY SHARES, AGGREGATING UP TO 1,000 MILLION (CONSTITUTING UP TO [ ]% OF THE POST-OFFER PAID-UP EQUITY SHARE CAPITAL, FOR SUBSCRIPTION BY ELIGIBLE EMPLOYEES (“EMPLOYEE RESERVATIONPORTION”). THE OFFER LESS THE EMPLOYEE RESERVATION PORTION IS HEREINAFTER REFERRED TO AS THE “NET OFFER”. THE OFFER AND THE NET OFFER SHALL CONSTITUTE [ ]% AND [ ]%, RESPECTIVELY, OF THE POSTOFFER PAID-UP EQUITY SHARE CAPITAL OF OUR COMPANY. THE FACE VALUE OF EQUITY SHARES IS 10 EACH. THE PRICE BAND AND THE MINIMUM BID LOT SHALL BE DECIDED BY OUR COMPANY AND THE SELLINGSHAREHOLDERS IN CONSULTATION WITH THE GLOBAL CO-ORDINATORS AND BOOK RUNNING LEAD MANAGERS (“GCBRLMS”), BOOK RUNNING LEAD MANAGERS (“BRLMS”) AND CO-BOOK RUNNING LEAD MANAGERS (“COBRLMS”) AND WILL BE ADVERTISED IN ALL EDITIONS OF FINANCIAL EXPRESS, AN ENGLISH NATIONAL DAILY NEWSPAPER, ALL EDITIONS OF JANSATTA, A HINDI NATIONAL DAILY NEWSPAPER AND THE CHENNAI EDITION OFMAKKAL KURAL, A TAMIL DAILY NEWSPAPER (TAMIL BEING THE REGIONAL LANGUAGE OF TAMIL NADU, WHERE OUR REGISTERED AND CORPORATE OFFICE IS LOCA TED) EACH WITH WIDE CIRCULATION AT LEAST TWOWORKING DAYS PRIOR TO THE BID/ OFFER OPENING DATE AND SHALL BE MADE AVAILABLE TO THE BSE LIMITED (“BSE”) AND THE NATIONAL STOCK EXCHANGE OF INDIA LIMITED (“NSE”, AND TOGETHER WITH BSE, THE“STOCK EXCHANGES”) FOR THE PURPOSE OF UPLOADING ON THEIR RESPECTIVE WEBSITES IN ACCORDANCE WITH THE SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS)REGULATIONS, 2018, AS AMENDED (THE “SEBI ICDR REGULATIONS”).In case of any revision in the Price Band, the Bid/ Offer Period will be extended by at least three additional Working Days after such revision in the Price Band, subject to the Bid/ Offer Period not exceeding 10 Working Days. In cases of force majeure,banking strike or similar circumstances, our Company and the Selling Shareholders may, in consultation with the GCBRLMs, BRLMs and the Co-BRLMs, for reasons to be recorded in writing, extend the Bid/ Offer Period for a minimum of threeWorking Days, subject to the Bid/ Offer Period not exceeding 10 Working Days. Any revision in the Price Band and the revised Bid/ Offer Period, if applicable, shall be widely disseminated by notification to the Stock Exchanges, by issuing a publicnotice, and also by indicating the change on the respective websites of the GCBRLMs, BRLMs and the Co-BRLMs and at the terminals of the Syndicate Members and by intimation to the Designated Intermediaries and the Sponsor Bank.The Offer is being made through the Book Building Process, in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended (“SCRR”) read with Regulation 31 of the SEBI ICDR Regulations and in compliance withRegulation 6(2) of the SEBI ICDR Regulations wherein not less than 75% of the Net Offer shall be available for allocation on a proportionate basis to Qualified Institutional Buyers (“QIBs”) (the “QIB Portion”), provided that our Company and theSelling Shareholders in consultation with the GCBRLMs, BRLMs and the Co-BRLMs may allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis. In the event of under-subscription, or non-allocation in the Anchor InvestorPortion, the balance Equity Shares shall be added to the QIB Portion. One-third of the Anchor Investor Portion shall be reserved for domestic Mutual Funds, subject to valid Bids being received from the domestic Mutual Funds at or above the AnchorInvestor Allocation Price. 5% of the QIB Portion (excluding the Anchor Investor Portion) shall be available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the QIB Portion shall be available for allocation on aproportionate basis to all QIB Bidders (other than Anchor Investors), including Mutual Funds, subject to valid Bids being received at or above the Offer Price. However, if the aggregate demand from Mutual Funds is less than 5% of the QIB Portion,the balance Equity Shares available for allocation in the Mutual Fund Portion will be added to the remaining QIB Portion for proportionate allocation to QIBs. Further, not more than 15% of the Net Offer shall be available for allocation on a proportionatebasis to Non-Institutional Bidders and not more than 10% of the Net Offer shall be available for allocation to RIBs in accordance with the SEBI ICDR Regulations, subject to valid Bids being received from them at or above the Offer Price. Further,Equity Shares will be allocated on a proportionate basis to Eligible Employees applying under the Employee Reservation Portion, subject to valid Bids received from them at or above the Offer Price. All Bidders (except Anchor Investors) are requiredto mandatorily utilise the Application Supported by Blocked Amount (“ASBA”) process providing details of their respective bank account (including UPI ID for RIBs using UPI Mechanism), in which the corresponding Bid Amounts will be blockedby the SCSBs or the Sponsor Bank, as applicable. Anchor Investors are not permitted to participate in the Offer through the ASBA process. For details, see “Offer Procedure” on page 423.RISKS IN RELATION TO THE FIRST OFFERThis being the first public issue of our Company, there has been no formal market for the Equity Shares of our Company. The face value of the Equity Shares is 10. The Floor Price, Cap Price and Offer Price should not be taken to be indicative of themarket price of the Equity Shares after the Equity Shares are listed. No assurance can be given regarding active and/or sustained trading in the Equity Shares nor regarding the price at which the Equity Shares will be traded after listing.GENERAL RISKInvestments in equity and equity-related securities involve a degree of risk and investors should not invest any funds in the Offer unless they can afford to take the risk of losing their entire investment. Investors are advised to read the risk factorscarefully before taking an investment decision in the Offer. For taking an investment decision, investors must rely on their own examination of our Company and the Offer, including the risks involved. The Equity Shares in the Offer have not beenrecommended or approved by the Securities and Exchange Board of India (“SEBI”), nor does SEBI guarantee the accuracy or adequacy of the contents of this Red Herring Prospectus. Specific attention of the investors is invited to “Risk Factors” onpage 26DISCLAIMER CLAUSE OF THE INSURANCE REGULATORY AND DEVELOPMENT AUTHORITY OF INDIA (“IRDAI”)Insurance Regulatory and Development Authority of India (“IRDAI”) does not undertake any responsibility for the financial soundness of the insurance company or for the correctness of any of the statements made or opinion expressedin this connection. Any approval by the IRDAI under the IRDAI Issuance of Capital Regulations (as defined in the section “Definitions and Abbreviations” on page 1) shall not in any manner be deemed to be or serve as a validation of therepresentations by our Company in this Red Herring Prospectus. This Offer has not been recommended or approved by IRDAI, nor does IRDAI guarantee the accuracy or adequacy of the contents/ information in this Red HerringProspectus. It is to be distinctly understood that this Red Herring Prospectus should not in any way be deemed or construed to have been approved or vetted by IRDAI.ISSUER’S AND SELLING SHAREHOLDER’S ABSOLUTE RESPONSIBILITYOur Company, having made all reasonable inquiries, accepts responsibility for and confirms that this Red Herring Prospectus contains all information with regard to our Company and the Offer, which is material in the context of the Offer, that theinformation contained in this Red Herring Prospectus is true and correct in all material aspects and is not misleading in any material respect, that opinions and intentions expressed herein are honestly held and that there are no other facts, the omissionof which makes this Red Herring Prospectus as a whole or any of such information or the expression of any such opinions or intentions misleading in any material respect. Each of the Selling Shareholders, severally and not jointly accepts responsibilityfor and confirms that the statements specifically made or confirmed by such Selling Shareholder in this Red Herring Prospectus to the extent of information specifically pertaining to itself and its respective portion of the Offered Shares and assumesresponsibility that such statements are true and correct in all material respects and not misleading in any material respect.LISTINGThe Equity Shares to be Allotted through the Red Herring Prospectus are proposed to be listed on the Stock Exchanges. Our Company has received ‘in-principle’ approvals from BSE and NSE for the listing of the Equity Shares pursuant to their lettersdated August 3, 2021 and September 23, 2021, respectively. For the purposes of the Offer, the Designated Stock Exchange shall be NSE. A signed copy of the Red Herring Prospectus and the Prospectus shall be delivered to the RoC in accordance withSections 26(4) and 32 of the Companies Act, 2013. For details of the material contracts and documents available for inspection from the date of the Red Herring Prospectus up to the Bid/ Offer Closing Date, see “Material Contracts and Documents forInspection” on page 444.BOOK RUNNING LEAD MANAGERS TO THE OFFERKotak Mahindra Capital CompanyLimited 1st Floor, 27 BKC, Plot No. 27G Block, Bandra Kurla Complex, Bandra(East), Mumbai 400 051Maharashtra, IndiaTel: 91 22 4336 0000E-mail: k.kotak.comContact Person: Ganesh RaneSEBI Registration No: INM000008704Axis Capital Limited Axis House, Level 1C-2 Wadia International CentrePandurang Budhkar Marg, WorliMumbai 400 025Maharashtra, IndiaTel: 91 22 4325 2183E-mail: ompliants@axiscap.inWebsite: www.axiscap.inContact Person: Simran GadhSEBI Registration No: INM000012029BofA Securities India Limited Ground Floor, A Wing One BKC, G BlockBandra Kurla Complex, Bandra (East)Mumbai 400 051Maharashtra, IndiaTel: 91 22 6632 8000E-mail: dg.star ipo@bofa.comInvestorgrievancee-mail:dg.india merchantbanking@bofa.comWebsite: www.ml-india.comContact Person: Deepa SalviSEBI Registration No: INM000011625REGISTRAR TO THE OFFERCitigroup Global Markets India PrivateLimited 1202, 12th Floor, First International FinanceCentre, G-Block, Bandra Kurla Complex,Bandra (East), Mumbai 400 098Maharashtra, IndiaTel: 91 22 6175 9999E-mail: o.in/rhtm/citigroupglobalscreen1.htmContact Person: Shashank PandeySEBI Registration No: INM000010718ICICI Securities Limited ICICI Venture House, Appasaheb MaratheMarg, Prabhadevi, Mumbai 400 025Maharashtra, IndiaTel: 91 22 6807 7100E-mail: l:customercare@icicisecurities.comWebsite: www.icicisecurities.comContact Person: Anurag Byas/ KristinaDiasSEBI Registration No: INM000011179KFin Technologies Private LimitedSelenium, Tower B, Plot No- 31 and 32FinancialDistrict,Nanakramguda,Serilingampally, HyderabadRangareedi 500 032Telangana, IndiaTel: 91 40 6716 2222/ 180034 54001E-mail: :einward.ris@kfintech.comWebsite: www.kfintech.comContact Person: M Murali KrishnaSEBI Registration No.: INR000000221BOOK RUNNING LEAD MANAGERS TO THE OFFERCLSA India Private Limited8/F Dalamal House, Nariman PointMumbai 400 021Maharashtra, IndiaTel: 91 22 6650 5050E-mail: twala/ Siddhant ThakurWebsite: BID/ OFFER OPENS ON(1)Credit Suisse Securities (India) PrivateLimited9th Floor, Ceejay House, Plot F ShivsagarEstate, Dr. Annie Besant Road, Worli,Mumbai 400 018Maharashtra, IndiaTel: 91 22 6777 ipo.htmlContact Person: Abhishek JoshiSEBI Registration No.: INM000011161Jefferies India Private Limited42/43, 2 North Avenue Maker Maxity,Bandra-Kurla ComplexBandra (East), Mumbai 400 051Maharashtra, IndiaTel: 91 22 4356 6000E-mail: l:jipl.grievance@jefferies.comWebsite: www.jefferies.comContact Person: Aman PuriSEBIRegistrationNo.:INM000011443November 30, 2021 (1)Ambit Private Limited*Ambit House, 449 Senapati BapatMargLower Parel, Mumbai 400 013Maharashtra, IndiaTel: 91 22 6623 3000E-mail: tomerservicemb@ambit.coWebsite: www.ambit.coContact Person: Nikhil BhiwapurkarSEBI Registration No.:INM000010585BID/ OFFER SCHEDULEBID/ OFFER CLOSES ONDAM Capital Advisors Limited*(Formerly IDFC Securities Limited)One BKC, Tower C, 15 th FloorUnit No.1511Bandra Kurla Complex, Bandra (East)Mumbai 400 051, Maharashtra, IndiaTel: 91 22 4202 2500E-mail: starhealth.ipo@damcapital.inWebsite: @damcapital.inContact Person: Chandresh SharmaSEBIRegistrationNumber:MB/INM000011336IIFL Securities Limited*10th Floor, IIFL CentreKamala City, Senapati Bapat MargLower Parel (West)Mumbai 400 013, Maharashtra, IndiaTel: 91 22 4646 4600E-mail: starhealth.ipo@iiflcap.comWebsite: ap.comContactPerson:PinakBhattacharyya / Harshvardhan JainSEBIRegistrationNumber:MB/INM000010940SBI Capital Markets Limited*202, Maker Tower ‘E’Cuffe Parade, Mumbai 400 005Maharashtra, IndiaTel: 91 22 2217 8300E-mail: investor.relations@sbicaps.comWebsite: www.sbicaps.comContact Person: Aditya er 2, 2021Our Company and the Selling Shareholders, in consultation with the GCBRLMs, BRLMs and the Co-BRLMs, may consider participation by Anchor Investors in accordance with the SEBI ICDR Regulations. The Anchor Investor Bid/Offer Periodshall be one Working Day prior to the Bid/ Offer Opening Date. Kotak, Axis, BofA, Citigroup and I-Sec are also acting as the GCBRLMs*Ambit, Dam Capital, IIFL Securities and SBICAP are also acting as the Co-BRLMs.

(This page is intentionally left blank)i

TABLE OF CONTENTSSECTION I: GENERAL . 1DEFINITIONS AND ABBREVIATIONS . 1OFFER DOCUMENT SUMMARY . 15CERTAIN CONVENTIONS, PRESENTATION OF FINANCIAL, INDUSTRY AND MARKET DATA AND CURRENCYOF PRESENTATION . 21FORWARD-LOOKING STATEMENTS . 24SECTION II: RISK FACTORS. 26SECTION III: INTRODUCTION . 62THE OFFER . 62SUMMARY OF FINANCIAL INFORMATION. 64GENERAL INFORMATION . 67CAPITAL STRUCTURE . 78OBJECTS OF THE OFFER . 101BASIS FOR OFFER PRICE . 106STATEMENT OF SPECIAL TAX BENEFITS . 109SECTION IV: ABOUT OUR COMPANY . 117INDUSTRY OVERVIEW . 117OUR BUSINESS. 161KEY REGULATIONS AND POLICIES . 189HISTORY AND CERTAIN CORPORATE MATTERS . 204OUR MANAGEMENT . 213OUR PROMOTERS AND PROMOTER GROUP . 235OUR GROUP COMPANIES . 241DIVIDEND POLICY . 243SECTION V: FINANCIAL INFORMATION. 244FINANCIAL STATEMENTS . 244OTHER FINANCIAL INFORMATION . 335ADDITIONAL DISCLOSURES OF FINANCIAL STATEMENTS UNDER IRDAI ISSUANCE OF CAPITALREGULATIONS . 336MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. 343CAPITALISATION STATEMENT . 372FINANCIAL INDEBTEDNESS . 373SECTION VI: LEGAL AND OTHER INFORMATION. 376OUTSTANDING LITIGATION AND MATERIAL DEVELOPMENTS. 376GOVERNMENT AND OTHER APPROVALS. 387OTHER REGULATORY AND STATUTORY DISCLOSURES . 391SECTION VII: OFFER INFORMATION . 413TERMS OF THE OFFER . 413OFFER STRUCTURE. 419OFFER PROCEDURE . 423RESTRICTIONS ON FOREIGN OWNERSHIP OF INDIAN SECURITIES . 439SECTION VIII: DESCRIPTION OF EQUITY SHARES AND TERMS OF ARTICLES OF ASSOCIATION . 440SECTION IX: OTHER INFORMATION . 444MATERIAL CONTRACTS AND DOCUMENTS FOR INSPECTION . 444DECLARATION . 448i

SECTION I: GENERALDEFINITIONS AND ABBREVIATIONSThis Red Herring Prospectus uses certain definitions and abbreviations which, unless the context otherwise indicates or implies,shall have the meaning as provided below. References to any legislation, act, regulation, rules, guidelines or policies shall beto such legislation, act, regulation, rules, guidelines or policies as amended, supplemented or re-enacted from time to time, andany reference to a statutory provision shall include any subordinate legislation made from time to time under that provision.The words and expressions used in this Red Herring Prospectus but not defined herein shall have, to the extent applicable, thesame meaning ascribed to such terms under the SEBI ICDR Regulations, the Companies Act, the SCRA, the Depositories Actand the rules and regulations made thereunder. Notwithstanding the foregoing, the terms used in “Industry Overview”, “KeyRegulations and Policies”, “Statement of Special Tax Benefits”, “Financial Statements”, “Basis for Offer Price”, “Historyand Certain Corporate Matters”, “Financial Indebtedness”, “Other Regulatory and Statutory Disclosures”, “OutstandingLitigation and Material Developments” and “Description of Equity Shares and Terms of Articles of Association” on pages117, 189, 109, 244, 106, 204, 373, 391, 376 and 440, respectively, shall have the meaning ascribed to them in the relevantsection.General TermsTermDescriptionour Company, the Company, the Star Health and Allied Insurance Company Limited, a company incorporated under the Companies Act,Issuer1956 and having its Registered and Corporate Office at No.1, New Tank Street, Valluvarkottam HighRoad, Nungambakkam, Chennai, Tamil Nadu 600 034we, us or ourUnless the context otherwise indicates or implies, refers to our CompanyCompany Related TermsTermAppointed ActuaryArticles of Association or AoAAudit CommitteeDescriptionThe appointed actuary of our Company namely, Chandra Shekhar DwivediArticles of association of our Company, as amendedThe audit committee of our Company, constituted in accordance with the applicable provisions of theCompanies Act, 2013 and the Listing Regulations and as described in “Our Management” on page 221Auditors or Statutory Auditors or M/s Brahmayya & Co., Chartered Accountants and M/S. V Sankar Aiyar & Co, Chartered Accountants,Joint Auditorscurrent joint statutory auditors of our CompanyBoard or Board of DirectorsBoard of directors of our CompanyChairman and CEOChairman and CEO of our Company, namely Venkatasamy JagannathanCorporate Social ResponsibilityThe corporate social responsibility committee of our Company constituted in accordance with theCommitteeapplicable provisions of the Companies Act, 2013 and as described in “Our Management” on page 225CRISIL ReportReport titled “Analysis of Health Insurance Industry in India” issued in November, 2021 issued byCRISIL ResearchDirector(s)The directors on the Board of our CompanyEquity SharesEquity shares of our Company of face value of 10 eachESES 2007Employee Sweat Equity Scheme, 2007ESOP Plan 2019Star Health and Allied Insurance Company Limited Employee Stock Option Plan 2019ESOP Plan 2021Star Health and Allied Insurance Company Limited Employee Stock Option Plan 2021Group CompanyOur group company, namely, Airpay Payment Services Private Limited as disclosed in “Our GroupCompanies” on page 241Independent DirectorsIndependent directors on the Board, as disclosed in “Our Management” on page 213Investment CommitteeThe investment committee of our Company as described in “Our Management” on page 226IPO CommitteeThe IPO committee of our Company as described in “Our Management” on page 228Key Managerial Personnel orKey managerial personnel of our Company in accordance with Regulation 2(1)(bb) of the SEBI ICDRKMPRegulations as disclosed in “Our Management” on page 232Managing DirectorsThe Managing Directors of our Company, namely Subbarayan Prakash and Anand Shankar Roy.Memorandum of Association orMemorandum of association of our Company, as amendedMoANomination and Remuneration Nomination and remuneration committee of our Company, constituted in accordance with the applicableCommitteeprovisions of the Companies Act, 2013 and the Listing Regulations and as described in “OurManagement” on page 223OPCO Promoters SPAAmended and restated OPCO Promoters Share Purchase Agreement dated February 1, 2019 enteredinto amongst our Company, certain shareholders, Safecrop Holdings Private Limited, WestBridge AIFI, Rakesh Jhunjhunwala and such other persons as may be informed to the other parties in accordancewith this agreement, MIO Star, MIO IV Star, Madison India Opportunities Trust Fund, the US Entitiesas amended by a deed of amendment dated March 28, 2019; November 17, 2020 and September 29,2021OPCO Promoters SPA SellersOPCO Promoters SPA Sellers means Essa Abdullah Ahmed Al Ghurair, Syed Mohamed Salahuddin,Hameed Syed Salahuddin. Ahmed Syed Salahuddin and Arif Buhary RahmanOther Selling ShareholdersApis Growth 6 Limited, MIO IV Star, University of Notre Dame DU LAC, MIO Star, ROC Capital Pty1

TermDescriptionLimited, Venkatasamy Jagannathan, Sai Satish and Berjis Minoo DesaiPolicyholdersProtection The policyholders protection committee of our Company as described in “Our Management” on pageCommittee225Promoter GroupEntities and individuals constituting the promoter group of our Company in terms of Regulation 2(1)(pp)of the SEBI ICDR Regulations, as disclosed in “Our Promoters and Promoter Group” on page 237PromoterGroupSelling MMPL Trust and Konark TrustShareholdersPromoter Selling ShareholderSafecrop Investments India LLPPromotersOur Promoters, namely, Safecrop Investments India LLP, WestBridge AIF I and Rakesh JhunjhunwalaRegistered and Corporate Office Registered and corporate office of our Company located at No.1, New Tank Street, ValluvarkottamHigh Road, Nungambakkam, Chennai, Tamil Nadu 600 034Registrar of Companies or RoCRegistrar of Companies, Tamil Nadu at ChennaiRestated Financial Informati

Our Company was incorporated as Star Health and Allied Insurance Company Limited, a public limited company, at Chennai under the Companies Act, 1956 on June 17, 2005 and was granted the certificate of incorporation by the Registrar of Companies, Tamil Nadu at Chennai. Our Company was granted its certificate for commencement of business on .